Antares Pharma reported $41.53M in Operating Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8869M 114M
Abbvie ABBV:US $ 11288M 2467M
Adma Biologics ADMA:US $ 16.94M 33.64M
Aerie Pharmaceuticals AERI:US $ 51.45M 12.03M
Ani Pharmaceuticals ANIP:US $ 86.77M 3.1M
Atrion ATRI:US 37.85M 5.4M
Becton, Dickinson and BDX:US $ 4106M 253M
Cara Therapeutics CARA:US $ 27.48M 5.23M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Horizon Pharma HZNP:US $ 787.85M 96.93M
JAZZ PHA JAZZ:US $ 847.33M 121.16M
Meridian Bioscience VIVO:US $ 74.45M 638K
Pacira Pharmaceuticals PCRX:US $ 138.18M 2.42M
Pfizer PFE:US $ 15640M 148M
Revance Therapeutics RVNC:US $ 86.21M 1.27M
Sientra SIEN:US 37.45M 42K
Supernus Pharmaceuticals SUPN:US $ 158.7M 8.17M
Teva Pharmaceutical TEVA:IT 4.74B 361M
Teva Pharmaceutical Industries TEVA:US 4.74B 361M